Synapse

← Annual Review of Cancer Biology

Papers in Annual Review of Cancer Biology

Page 3 · newest first

  1. Single-Cell Epigenomics Reveals Mechanisms of Cancer ProgressionAnnual Review of Cancer Biology · 2022
  2. Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint BlockadeAnnual Review of Cancer Biology · 2021
  3. CRISPR Screens to Identify Regulators of Tumor ImmunityAnnual Review of Cancer Biology · 2021
  4. TGFβ: Signaling Blockade for Cancer ImmunotherapyAnnual Review of Cancer Biology · 2021
  5. Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical ApproachesAnnual Review of Cancer Biology · 2021
  6. Targeting KRAS G12C with Covalent InhibitorsAnnual Review of Cancer Biology · 2021
  7. Tracing and Targeting the Origins of Childhood CancerAnnual Review of Cancer Biology · 2021
  8. Targeting Solid Tumors with Bispecific T Cell Engager Immune TherapyAnnual Review of Cancer Biology · 2021
  9. The Metabolic Relationship Between Viral Infection and CancerAnnual Review of Cancer Biology · 2021
  10. Humanized Mouse Models to Evaluate Cancer ImmunotherapeuticsAnnual Review of Cancer Biology · 2021
  11. Personal Neoantigen Vaccines for the Treatment of CancerAnnual Review of Cancer Biology · 2021
  12. Telomeres and Cancer: Resolving the ParadoxAnnual Review of Cancer Biology · 2021
  13. Developmental Insights into Lung CancerAnnual Review of Cancer Biology · 2021
  14. Cancer Dependencies: PRMT5 and MAT2A in MTAP/p16-Deleted CancersAnnual Review of Cancer Biology · 2020
  15. Zena Werb (1945–2020): Matrix Metalloproteinases, Microenvironments, and MentoringAnnual Review of Cancer Biology · 2020
  16. Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer TherapeuticsAnnual Review of Cancer Biology · 2020
  17. Small-Molecule Approaches to Targeted Protein DegradationAnnual Review of Cancer Biology · 2020
  18. Immunometabolism in the Tumor MicroenvironmentAnnual Review of Cancer Biology · 2020
  19. Cancer Immunotherapy and the Nectin FamilyAnnual Review of Cancer Biology · 2020
  20. Molecular Biology of Childhood LeukemiaAnnual Review of Cancer Biology · 2020
  21. The Role of Epigenetic Mechanisms in B Cell Lymphoma PathogenesisAnnual Review of Cancer Biology · 2020
  22. The Multifaceted Role of Regulatory T Cells in Breast CancerAnnual Review of Cancer Biology · 2020
  23. Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and AgingAnnual Review of Cancer Biology · 2020
  24. Reeling in the Zebrafish Cancer ModelsAnnual Review of Cancer Biology · 2020
  25. The Intriguing Clinical Success of BCL-2 Inhibition in Acute Myeloid LeukemiaAnnual Review of Cancer Biology · 2020
  26. Molecular Heterogeneity and Evolution in Breast CancerAnnual Review of Cancer Biology · 2020
  27. Myeloid-Derived Suppressor Cells: Facilitators of Cancer and Obesity-Induced CancerAnnual Review of Cancer Biology · 2020
  28. Regulatory T Cells in CancerAnnual Review of Cancer Biology · 2020
  29. Engineering T Cells to Treat Cancer: The Convergence of Immuno-Oncology and Synthetic BiologyAnnual Review of Cancer Biology · 2020
  30. The Pleiotropic Role of the KEAP1/NRF2 Pathway in CancerAnnual Review of Cancer Biology · 2020
  31. Immune-Based Approaches for the Treatment of Pediatric MalignanciesAnnual Review of Cancer Biology · 2020
  32. Cancer-Associated Cachexia: A Systemic Consequence of Cancer ProgressionAnnual Review of Cancer Biology · 2019
  33. The Role of Translation Control in Tumorigenesis and Its Therapeutic ImplicationsAnnual Review of Cancer Biology · 2019
  34. The Neural Regulation of CancerAnnual Review of Cancer Biology · 2019
  35. Biomarkers for Response to Immune Checkpoint BlockadeAnnual Review of Cancer Biology · 2019
  36. The Epithelial-to-Mesenchymal Transition in Development and CancerAnnual Review of Cancer Biology · 2019
  37. RNA Modifications in Cancer: Functions, Mechanisms, and Therapeutic ImplicationsAnnual Review of Cancer Biology · 2019
  38. Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?Annual Review of Cancer Biology · 2019
  39. Toward Targeting Antiapoptotic MCL-1 for Cancer TherapyAnnual Review of Cancer Biology · 2019
  40. Acquired Resistance in Lung CancerAnnual Review of Cancer Biology · 2019
  41. Nongenetic Mechanisms of Drug Resistance in MelanomaAnnual Review of Cancer Biology · 2019
  42. WNT and β-Catenin in Cancer: Genes and TherapyAnnual Review of Cancer Biology · 2019
  43. Deregulation of Chromosome Segregation and CancerAnnual Review of Cancer Biology · 2019
  44. Reactivation of Endogenous Retroelements in Cancer Development and TherapyAnnual Review of Cancer Biology · 2019
  45. Lactate and Acidity in the Cancer MicroenvironmentAnnual Review of Cancer Biology · 2019
  46. Metabolism in the Tumor MicroenvironmentAnnual Review of Cancer Biology · 2019
  47. Metabolic Drivers in Hereditary Cancer SyndromesAnnual Review of Cancer Biology · 2019
  48. Mitophagy and Mitochondrial Dysfunction in CancerAnnual Review of Cancer Biology · 2019
  49. AMP-Activated Protein Kinase: Friend or Foe in Cancer?Annual Review of Cancer Biology · 2019
  50. Targeting MYC Proteins for Tumor TherapyAnnual Review of Cancer Biology · 2019